AbbVie
ABBV
ABBV
1,635 hedge funds and large institutions have $62.5B invested in AbbVie in 2016 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 727 increasing their positions, 601 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding
Funds holding: 1,633 → 1,635 (+2)
5% less capital invested
Capital invested by funds: $65.6B → $62.5B (-$3.04B)
16% less funds holding in top 10
Funds holding in top 10: 96 → 81 (-15)
Holders
1,635
Holding in Top 10
81
Calls
$651M
Puts
$632M
Top Buyers
| 1 | +$635M | |
| 2 | +$304M | |
| 3 | +$198M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$198M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$183M |
Top Sellers
| 1 | -$1.03B | |
| 2 | -$119M | |
| 3 | -$108M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$107M |
| 5 |
Bank of New York Mellon
New York
|
-$104M |